Mark R. Wieland
- Ophthalmology top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Endocrinology top 10%
- Co-authors
- Brandon BusbeeAllen C. HoPhillip LaiRoman G. RubioCarl D. RegilloZhengrong LiRahul N. KhuranaLawrence J. Singerman
- Topics
- Retinal Diseases and Treatments (16 papers)Retinal and Optic Conditions (9 papers)Retinal Imaging and Analysis (8 papers)
- Partner nations
- United StatesAustriaSwitzerland
In The Last Decade
Mark R. Wieland
24 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Ophthalmology 972
- Radiology, Nuclear Medicine and Imaging 770
- Molecular Biology 155
- Public Health, Environmental and Occupational Health 76
- Endocrinology 61
Countries citing papers authored by Mark R. Wieland
This map shows the geographic impact of Mark R. Wieland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Wieland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Wieland more than expected).
Fields of papers citing papers by Mark R. Wieland
This network shows the impact of papers produced by Mark R. Wieland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Wieland. The network helps show where Mark R. Wieland may publish in the future.
Co-authorship network of co-authors of Mark R. Wieland
This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Wieland. A scholar is included among the top collaborators of Mark R. Wieland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Wieland. Mark R. Wieland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 12 | |
| 3 | 9 | |
| 4 | 10 | |
| 5 | 10 | |
| 6 | Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial | 2 |
| 7 | 179 | |
| 8 | 3 | |
| 9 | 24 | |
| 10 | 22 | |
| 11 | 49 | |
| 12 | 5 | |
| 13 | 21 | |
| 14 | Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degenerationbreakdown → | 486 |
| 15 | 12 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 21 | |
| 19 | 41 | |
| 20 | 3 |
About Mark R. Wieland
Mark R. Wieland is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Medicine, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (16 papers), Retinal and Optic Conditions (9 papers) and Retinal Imaging and Analysis (8 papers). The work is most often cited by research in Ophthalmology (972 citations), Radiology, Nuclear Medicine and Imaging (770 citations) and Endocrinology (61 citations). Mark R. Wieland has collaborated with scholars based in United States, Austria and Switzerland. Frequent co-authors include Brandon Busbee, Allen C. Ho, Phillip Lai, Roman G. Rubio, Carl D. Regillo, Zhengrong Li, Rahul N. Khurana, Lawrence J. Singerman, Andreas Weichselberger and Pravin U. Dugel. Their work appears in journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.